Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sporadic Inclusion Body Myositis”

53 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 53 results

Testing effectiveness (Phase 2)Study completedNCT02753530
What this trial is testing

Study of Arimoclomol in Inclusion Body Myositis (IBM)

Who this might be right for
Inclusion Body Myositis
ZevraDenmark 152
Large-scale testing (Phase 3)Study completedNCT01165008
What this trial is testing

Anakinra in Myositis

Who this might be right for
PolymyositisDermatomyositisInclusion Body Myositis
Karolinska Institutet
Not applicableLooking for participantsNCT07374107
What this trial is testing

MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)

Who this might be right for
IBMIIMMyositis+9 more
Myositis International Health & Research Collaborative Alliance Foundation 700
Testing effectiveness (Phase 2)Study completedNCT00079768
What this trial is testing

Alemtuzumab to Treat Sporadic Inclusion Body Myositis

Who this might be right for
Myositis, Inclusion Body
National Institute of Neurological Disorders and Stroke (NINDS) 20
Not applicableEnrolling By InvitationNCT07072676
What this trial is testing

The Use of Assistive Gait Devices Can Reduce the Risk of Falls in Patients With Neuromuscular Diseases Following a Training Period.

Who this might be right for
Inclusion Body MyositisMyotonic Dystrophy 1Myotonic Dystrophy 2+10 more
LMU Klinikum 30
Large-scale testing (Phase 3)Study completedNCT02250443
What this trial is testing

Study of Long-term Safety, Efficacy Tolerability of BYM338 in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)
Novartis Pharmaceuticals 10
Not applicableActive Not RecruitingNCT01171573
What this trial is testing

Investigating Genes in Patients With Polymyositis and Dermatomyositis

Who this might be right for
Myositis
Northern Care Alliance NHS Foundation Trust 1,000
Not applicableStudy completedNCT04907162
What this trial is testing

Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders

Who this might be right for
Pompe Disease (Late-onset)Myotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2+4 more
LMU Klinikum 82
Large-scale testing (Phase 3)Active Not RecruitingNCT06450886
What this trial is testing

Long-term Extension Study of Ulviprubart (ABC008) in Subjects With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis (IBM)
Abcuro, Inc. 270
Large-scale testing (Phase 3)Study completedNCT05721573
What this trial is testing

Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Abcuro, Inc. 272
Large-scale testing (Phase 3)Study completedNCT02481453
What this trial is testing

Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis (IBM)
Institut National de la Santé Et de la Recherche Médicale, France 44
Very early researchLooking for participantsNCT06479863
What this trial is testing

Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Sporadic Inclusion Body Myositis

Who this might be right for
Sporadic Inclusion Body Myositis (sIBM)Idiopathic Inflammatory Myopathies
Austin Neuromuscular Center 10
Early research (Phase 1)UnknownNCT02483845
What this trial is testing

Natalizumab in Inclusion Body Myositis (IBM)

Who this might be right for
Inclusion Body Myositis (IBM)
Phoenix Neurological Associates, LTD 6
Not applicableEnrolling By InvitationNCT06605612
What this trial is testing

Development and Validation of the FBIndex to Determine the Risk of Falls for Patients With Neuromuscular Disorders

Who this might be right for
Inclusion Body MyositisMyotonic DystrophyLimb-girdle and Facioscapulohumeral Muscular Dystrophies+9 more
LMU Klinikum 108
Not applicableStudy completedNCT01734369
What this trial is testing

Environmental Risk Factors for Myositis in Military Personnel

Who this might be right for
DermatomyositisAdult PolymyositisInclusion Body Myositis+1 more
National Institute of Environmental Health Sciences (NIEHS) 37
Early research (Phase 1)UnknownNCT05032131
What this trial is testing

Cell Therapy for IBM by Muscle Injection of ADSVF

Who this might be right for
Inclusion Body Myositis
Assistance Publique - Hôpitaux de Paris 32
Not applicableLooking for participantsNCT07478172
What this trial is testing

Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Neuromuscular Disease

Who this might be right for
Neuromuscular Diseases (NMD)Amyotrophic Lateral SclerosisMyasthenia Gravis+15 more
University of Missouri-Columbia 50
Not applicableStudy completedNCT00898989
What this trial is testing

Muscle Strength and Inflammatory Response in Patients With Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Institut de Myologie, France 42
Large-scale testing (Phase 3)Study completedNCT00769860
What this trial is testing

Arimoclomol in Sporadic Inclusion Body Myositis

Who this might be right for
Inclusion Body Myositis
Richard Barohn, MD 24
Not applicableActive Not RecruitingNCT06153108
What this trial is testing

Monitoring Biomarker for Detecting Change in Physical Activity and Limb Function in Inclusion Body Myositis Over Time

Who this might be right for
Inclusion Body Myositis
University of Kansas Medical Center 20
Load More Results